Ophthalmic Emulsion ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
51	Scleroderma	1
53	Sjogren syndrome	1

51. Scleroderma

---

Clinical trials : 525 /  Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025818 (ClinicalTrials.gov)	May 2001	26/10/2001	Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome		Keratoconjunctivitis Sicca;Sjogren's Syndrome;Lupus Erythematosus, Systemic;Arthritis, Rheumatoid;Scleroderma, Systemic	Drug: Ophthalmic Emulsion	Allergan	NULL	Completed	18 Years	N/A	Both	290	Phase 3	United States

53. Sjogren syndrome

---

Clinical trials : 305 /  Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025818 (ClinicalTrials.gov)	May 2001	26/10/2001	Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome		Keratoconjunctivitis Sicca;Sjogren's Syndrome;Lupus Erythematosus, Systemic;Arthritis, Rheumatoid;Scleroderma, Systemic	Drug: Ophthalmic Emulsion	Allergan	NULL	Completed	18 Years	N/A	Both	290	Phase 3	United States